| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |